Nesina Tablets 12.5mg, manufactured by Teijin Pharma, contain Alogliptin benzoate, a DPP-4 inhibitor used for improved glycemic control in type 2 diabetes mellitus. This medication is a 12.5 mg 1 tablet with YJ code 3969012F2021.
Nesina Tablets 12.5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
